Source: Annual Congress 2007 - Clinical aspects of idiopathic pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Key, B. Chakrabarti, C. Warburton, S. Jack, D. Davies, J. Earis (Liverpool, Salford, United Kingdom). Is there a relationship between quality of life and exercise performance in idiopathic pulmonary fibrosis (IPF)?. Eur Respir J 2007; 30: Suppl. 51, 3428

Member's Comments

No comment yet.

Related content which might interest you: Relationship between patient pulmonary function, exercise capacity and quality of life in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - New issues in pulmonary function Year: 2012 Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study Source: Breathe, 15 (2) 144; 10.1183/20734735.0016-2019 Year: 2019 The efficacy of a walk-bike on quality of life and exercise capacity in patients with idiopathic pulmonary fibrosis (IPF). A pilot study Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Quality of life (HQoL) and well-being in patients with idiopathic pulmonary fibrosis (IPF): the role of portable oxygen Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Burden of idiopathic pulmonary fibrosis (IPF) on quality of life (QoL), work productivity, and healthcare use Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020 The effect of pulmonary rehabilitation on exercise tolerance pulmonary function dyspnea and quality of life in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013 The development of a measure to better understand patient experiences with pirfenidone and nintedanib for the treatment of idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Item generation for a patient reported outcome measure (PRoM) in idiopathic pulmonary fibrosis (IPF): Application of consensus methods Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Correlation between pulmonary function test (PFT) parameters and quality of life (QoL) and dyspnea in stable chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007 Quality of life of patients with idiopathic pulmonary fibrosis (IPF) - What can the Australian IPF registry tell us? Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Patients’ expectations and quality of life before introduction of pirfenidone used in idiopathic pulmonary fibrosis. Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments Year: 2018 Adapted physical activity intervention for improvement of quality of life in patients with idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation Year: 2020 Pulmonary function, inflammation, exercise capacity and quality of life in cystic fibrosis Source: Eur Respir J 2001; 17: 712-715 Year: 2001 Are there differences in response to pulmonary rehabilitation (PR) in idiopathic pulmonary fibrosis (IPF) and COPD patients? Source: International Congress 2017 – New insights into pulmonary rehabilitation in patients with chronic lung diseases Year: 2017 Does delay in review of newly-diagnosed idiopathic pulmonary fibrosis (IPF) worsen outcomes? Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018 Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1) Source: Eur Respir J 2010; 35: 118-123 Year: 2010 Can clinical data predict rapid decline of lung function in idiopathic pulmonary fibrosis (IPF) patients? Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017 Predicting life expectancy for pirfenidone and best supportive care (BSC) in idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – IPF treatment II Year: 2016 Comparison of exercise capacity, physical activity level and quality of life in patients with different severity of non-cystic fibrosis bronchiectasis> Source: Virtual Congress 2021 – Peripheral muscle function, exercise capacity and functional status in respiratory disease Year: 2021 The impact of treatment of chronic obstructive pulmonary disease (COPD) on functional status and quality of life of patients Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012